Kassiani-Maria Nastouli

Dr. Kassiani-Maria Nastouli

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MBMaria Bozika
Maria Bozika
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
Michail PapafaklisMichail Papafaklis
Michail Papafaklis
ISIoannis Skalidis
Ioannis Skalidis
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
A revolutionary non-invasive method for the thorough evaluation of coronary artery disease (CAD) is fractional flow reserve (FFR) obtained from coronary computed tomography angiography (CCTA). Computed tomography-derived FFR (FFRCT) assesses both the anatomical and functional significance of coronary lesions simultaneously by utilizing sophisticated computational models, including computational fluid dynamics, machine learning (ML), and Artificial Intelligence (AI) methods. The technological development, validation research, clinical uses, and real-world constraints of FFRCT are compiled in this review. Large multicenter trials and registries consistently show that FFRCT is a reliable gatekeeper to invasive coronary angiography (ICA) and increases diagnostic accuracy significantly when compared to coronary Computed Tomography Angiography (CTA) alone, especially in patients with intermediate-risk anatomy. Additionally, FFRCT has demonstrated benefits in populations with in-stent restenosis (ISR) and in virtual procedural planning. Notwithstanding its advantages, the technique still requires high-quality imaging, and its practical application is constrained by expenses, processing requirements, and image distortions. Continuous developments in automation and deep learning should improve accessibility, effectiveness, and workflow integration in clinical settings. FFRCT is expected to become more and more important in the individualized treatment of CAD by minimizing unnecessary invasive procedures and improving patient selection for revascularization.

27 April 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Georgios LeventopoulosGeorgios Leventopoulos
Georgios Leventopoulos
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
MBMaria Bozika
Maria Bozika
HPHELEN PAPASTAVROU
HELEN PAPASTAVROU
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
PDPeriklis Davlouros
Periklis Davlouros
Cardiac resynchronization therapy (CRT) using biventricular (BiV) pacing is the standard treatment for heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) and electrical dyssynchrony. However, one in three patients remains a non-responder. Left bundle branch area pacing (LBBAP) could represent a more physiological alternative, but its effectiveness is limited in cases of atypical left bundle branch block (LBBB) or intraventricular conduction delay (IVCD). Left Bundle Branch Pacing Optimized cardiac resynchronization therapy (LOT-CRT) integrates LBBAP with coronary sinus (CS) lead pacing to improve electrical synchrony and clinical outcomes. This review evaluates the feasibility, advantages, disadvantages, and clinical outcomes of LOT-CRT. Additionally, we describe our center’s experience and propose an evidence-based implantation algorithm. A review of published studies investigating LOT-CRT was conducted, comparing its effectiveness with BiV-CRT and LBBAP alone using QRS narrowing, LVEF improvement, left ventricular remodeling, New York Heart Association (NYHA) class changes and NT-proBNP levels. It was found that LOT-CRT outperforms BiV-CRT or LBBAP alone in selected populations, at the cost of higher clinical skills, longer procedural times, and specific device setups. Randomized trials are underway to further define its role in clinical practice.

6 November 2024 in Coronary Artery Disease
Verified
Journal Article
Closed access
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
MBMaria Bozika
Maria Bozika
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
DCDimitrios-David Chlorogiannis
Dimitrios-David Chlorogiannis
KDKyriakos Dimitriadis
Kyriakos Dimitriadis
GTGrigorios Tsigkas
Grigorios Tsigkas
Patients suffering from chronic kidney disease (CKD) have higher ischemic and bleeding risk compared with patients with normal renal function. The aim of our systematic review and meta-analysis is to compare shortened (≤3 months) dual antiplatelet therapy (DAPT) with longer DAPT in patients with CKD undergoing percutaneous coronary interventions. We systematically screened three major databases (Medline, Cochrane Central Register of Controlled Trials, and Scopus) searching for randomized-controlled trials or subanalyses of them, which compared shortened (S-DAPT) to longer (L-DAPT) regimens of DAPT in patients with CKD. The primary endpoint is the net adverse clinical events (NACE) and the secondary is major adverse cardiac events (MACE), and bleedings. Subgroup analyses included studies using only P2Y12 monotherapy, ticagrelor-based regimens, 1- and 3-month duration of DAPT. A total of 10 studies and 6688 patients were included in our analysis. No significant differences regarding NACE (RR: 0.97, 95% CI: 0.84–1.12, I 2 = 0%), MACE (RR: 1.00, 95% CI: 0.85–1.117, I 2 = 0%), and bleedings (RR: 0.78, 95% CI: 0.59–1.03, I 2 = 25%) were observed between S-DAPT and L-DAPT in our meta-analysis. The findings from the subgroup analyses were in accordance with total findings; bleedings were significantly reduced in S-DAPT when only studies with 3-month duration of DAPT were analyzed (RR: 0.58, 95% CI: 0.40–0.85, I 2 = 0%). Our systematic review and meta-analysis showed that no significant differences were observed between patients treated with S-DAPT or L-DAPT in the terms of MACE, NACE, and bleedings in patients with CKD. When it is required, S-DAPT could be considered in patients with CKD.

8 March 2023 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
AMAthanasios Moulias
Athanasios Moulias
RKRafail Koros
Rafail Koros
APAngeliki Papageorgiou
Angeliki Papageorgiou
PPPanagiotis Patrinos
Panagiotis Patrinos
PSPanagiota Spyropoulou
Panagiota Spyropoulou
PDPeriklis Davlouros
Periklis Davlouros
Coronary bifurcation is defined by the European Bifurcation Consensus as a coronary artery stenosis adjacent to the origin of a significant side branch. Its anatomy is composed of 3 different segments: proximal main vessel, distal main vessel and side branch. Coronary artery bifurcation lesions are encountered in approximately 15–20% of all percutaneous coronary interventions and constitute a complex subgroup of lesions characterized by lower procedural success rates and higher rates of adverse outcomes. In recent years, a growing focus in the European and Japanese bifurcation club meetings has been the emerging role of intravascular imaging, in guiding successful bifurcation percutaneous coronary interventions (PCI). In this review we will present the main ways optical coherence tomography (OCT) can be used to improve outcomes during bifurcation PCI.

Verified
Journal Article
Open access
PDF file
Grigorios TsigkasGrigorios Tsigkas
Grigorios Tsigkas
Kassiani-Maria NastouliKassiani-Maria Nastouli
Kassiani-Maria Nastouli
Anastasios ApostolosAnastasios Apostolos
Anastasios Apostolos
PSPanagiota Spyropoulou
Panagiota Spyropoulou
MBMaria Bozika
Maria Bozika
PDPeriklis Davlouros
Periklis Davlouros
Percutaneous Coronary Intervention (PCI) has advanced significantly with the incorporation of imaging and physiology assessment techniques. Fractional Flow Reserve (FFR) and Non-Hyperemic Pressure indices (NHPIs) provide information regarding the functional significance of coronary lesions, while Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) enhance anatomical characterization and guide stent implantation. This review explores the implementation of physiology- and imaging-guided strategies in clinical practice, comparing their efficacy and limitations. Novel technologies now allow for physiology estimation without hyperemic agents, and hybrid techniques, such as OCT-derived FFR, are increasingly integrated into clinical practice. These approaches offer the combined advantages of functional assessment and detailed anatomical imaging.

Verified
Journal Article
Open access
PDF file
Nicholas KounisNicholas Kounis
Nicholas Kounis
Cesare de GregorioCesare de Gregorio
Cesare de Gregorio
Ming-Yow HungMing-Yow Hung
Ming-Yow Hung
GGGrigorios Giamouzis
Grigorios Giamouzis
ΜΜΜαρινα Μιχαλάκη
Μαρινα Μιχαλάκη
IKIoanna C. Koniari
Ioanna C. Koniari
Mast cell degranulation and other interacting and linked cells, including T-lymphocytes, macrophages, eosinophils, and platelets, as well as a range of inflammatory mediators produced during an anaphylactic or allergic reaction, constitute the main causes of Kounis syndrome. Acute ischemia episodes, coronary spasm, atheromatous plaque erosion/rupture, and platelet activation can all be caused by histamine, tryptase, arachidonic acid derivatives, and chymase in the Kounis syndrome cascade. Kounis syndrome can be triggered by a variety of factors, including medications, hymenopteran stings, metals, foods, environmental exposures, illnesses, and immunizations. In addition, some unusual, rare, intriguing, and significant causes of Kounis syndrome have been discovered recently, namely the “kiss of death”, where human kissing and pet kissing can induce fatal Kounis syndrome. Moreover, the clinical conundrum is that several of the main drugs and substances used to treat myocardial infarction and Kounis syndrome, such as adrenaline (epinephrine), aspirin, atropine, clopidogrel, corticosteroids, heparins, protamine sulfate, and hirudotherapy can also initiate it. Therefore, physicians should be aware of this clinical discrepancy to prevent catastrophic consequences.